Thunbnail image
News   >  Gastroenterology   >  

New Enzyme Shows Promise for Reducing Digestive Discomfort from High FODMAP Foods

Published: 7/11/2024
      
Digestive health
High FODMAP foods
Fructans
Enzyme therapy
BIO-CAT
OPTIZIOME Fructanase
Gastrointestinal symptoms
Enzyme safety
Dietary supplements
Clinical trials

Key Takeaways

  • OPTIZIOME® Fructanase can reduce digestive discomfort from high FODMAP foods.
  • A Phase I clinical trial confirms the enzyme's safety and efficacy.
  • BIO-CAT is committed to advancing digestive health solutions.

Did You Know?

Did you know that around 20% of the global population experiences IBS, often triggered by high FODMAP foods?

Breakthrough in Digestive Health

BIO-CAT has revealed promising research about their new enzyme, OPTIZIOME® Fructanase, which aims to alleviate digestive issues caused by high FODMAP foods. These foods, which include certain vegetables, grains, and fruits, can cause discomfort due to their high content of fructans. Fructanase works by breaking down these fructans, potentially easing digestive problems.

The announcement follows the publication of a significant safety clinical trial in Gastro Hep Advances. The study was led by Nutrasource and demonstrates the enzyme's safety and its potential benefits for gastrointestinal health.

Clinical Trial Findings

The Phase I clinical trial involved 60 healthy participants between the ages of 20 and 65. The study was randomized, double-blind, and placebo-controlled to ensure reliable results. Participants who received high doses of fructanase reported that the supplement was well tolerated with no notable side effects.

Moreover, those in the fructanase group experienced fewer adverse events and no significant changes in their clinical parameters compared to the placebo group. These findings suggest that OPTIZIOME® Fructanase is a safe and effective solution to reduce discomfort from high FODMAP foods.

Positive Reception and Future Impact

Chris Schuler, CEO of BIO-CAT, emphasized the enzyme's importance: “Consumers are increasingly looking for healthier meal options, including foods high in FODMAPs. We are excited to offer a new solution that addresses the digestive challenges associated with these foods.”

Lois Lin, Medical Writer at SGS Nutrasource, also praised the collaboration and successful trial, stating that it stands as a testament to the dedication and hard work of all involved. She looks forward to further advancements and the market introduction of this novel enzyme.

BIO-CAT's Dedication to Digestive Health

BIO-CAT remains committed to enhancing digestive health through their innovative enzyme technologies. Established in 1988, the company continues to provide advanced solutions for various market sectors, including dietary supplements and food industries.

OPTIZIOME® branded solutions are part of BIO-CAT’s extensive product range, designed to improve overall well-being. Their state-of-the-art facilities in Virginia ensure the highest standards in research and quality testing.

In conclusion, OPTIZIOME® Fructanase holds promise for those struggling with digestive discomfort due to high FODMAP foods, and BIO-CAT's continued efforts in enzyme innovation are paving the way for better digestive health solutions.

References

  1. Gastro Hep Advances - Clinical Trial Publication
    https://gastrohep.advances.org/optiziome-fructanase-study
  2. FDA - New Dietary Ingredient Notifications
    https://www.fda.gov/food/new-dietary-ingredients
  3. Nutrasource - Clinical Trial Management
    https://www.nutrasource.ca/services/clinical-trials